BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16399976)

  • 1. Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia.
    Mallinger JB; Fisher SG; Brown T; Lamberti JS
    Psychiatr Serv; 2006 Jan; 57(1):133-6. PubMed ID: 16399976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
    Mallinger JB; Lamberti SJ
    J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clozapine use in Maryland and in Victoria, Australia.
    Conley RR; Kelly DL; Lambert TJ; Love RC
    Psychiatr Serv; 2005 Mar; 56(3):320-3. PubMed ID: 15746507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia.
    Kuno E; Rothbard AB
    Am J Psychiatry; 2002 Apr; 159(4):567-72. PubMed ID: 11925294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006.
    Sernyak MJ; Rosenheck RA
    Psychiatr Serv; 2008 May; 59(5):567-9. PubMed ID: 18451019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic and clinical variation in clozapine use in the United States.
    Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
    Psychiatr Serv; 2014 Feb; 65(2):186-92. PubMed ID: 24233347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
    Hamann J; Pfeiffer H; Leucht S; Kissling W
    Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in Psychotropic Medication Prescription for Adults With Schizophrenia in the United States.
    Bareis N; Olfson M; Wall M; Stroup TS
    Psychiatr Serv; 2022 May; 73(5):492-500. PubMed ID: 34587788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
    Velligan DI; Carroll C; Lage MJ; Fairman K
    Psychiatr Serv; 2015 Feb; 66(2):127-33. PubMed ID: 25321616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of psychotropic medication use by race among veterans with bipolar disorder.
    Kilbourne AM; Pincus HA
    Psychiatr Serv; 2006 Jan; 57(1):123-6. PubMed ID: 16399973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy and health care costs among patients with schizophrenia and newly diagnosed diabetes.
    Leslie DL; Rosenheck RA
    Psychiatr Serv; 2005 Jul; 56(7):803-9. PubMed ID: 16020811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence patterns with first- versus second-generation antipsychotics for newly diagnosed schizophrenia in Taiwan.
    Chang CM; Wu KY; Liang HY; Wu EC; Chen CY; Wu CS; Chen SJ; Chang TK; Tsai HJ
    Psychiatr Serv; 2012; 63(5):504-7. PubMed ID: 22549537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
    Wheeler A; Humberstone V; Robinson E; Sheridan J; Joyce P
    J Eval Clin Pract; 2009 Jun; 15(3):441-50. PubMed ID: 19366393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex, ethnicity, and antipsychotic medication use in patients with psychosis.
    Arnold LM; Strakowski SM; Schwiers ML; Amicone J; Fleck DE; Corey KB; Farrow JE
    Schizophr Res; 2004 Feb; 66(2-3):169-75. PubMed ID: 15061250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical decision making in antipsychotic drug choice for schizophrenia.
    Hamann J; Langer B; Leucht S; Busch R; Kissling W
    Am J Psychiatry; 2004 Jul; 161(7):1301-4. PubMed ID: 15229068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.